CEOi logo
A Shared Global Agenda to Fight Alzheimer's Disease
November 12, 2014 11:42 ET | USAgainstAlzheimer's
LAUSANNE, Switzerland, Nov. 12, 2014 (GLOBE NEWSWIRE) -- There is currently no cure for Alzheimer's disease and other dementias. The main barriers to the development of effective treatments for...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
November 03, 2014 08:02 ET | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...
DiamiR Announces Corporate Presentation at Life Sciences Summit 2014
October 22, 2014 08:02 ET | DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - October 22, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Grant From The Michael J. Fox Foundation for Parkinson's Research to Advance Assessment of Brain-Enriched microRNA Biomarkers in Plasma
July 14, 2014 11:00 ET | DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 14, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
Keep Memory Alive's 18th "Power of Love" Gala in Las Vegas
April 28, 2014 09:27 ET | Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, April 28, 2014 (GLOBE NEWSWIRE) -- On Saturday, April 26, 2014, some of the biggest names in the entertainment industry honored Gloria and Emilio Estefan at the 18th annual "Power of Love"...
DiamiR Announces Poster Presentation on Detection and Differentiation of Neurodegenerative Diseases at the Biomarkers & Diagnostics World Congress 2014
April 28, 2014 08:00 ET | DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - April 28, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...
desc
Alzheimer's Drug Discovery Foundation and Children's Tumor Foundation announce Partnership to Provide Drug Discovery Resources for Research Community
March 14, 2014 10:31 ET | Children's Tumor Foundation
NEW YORK, N.Y., March 14, 2014 (GLOBE NEWSWIRE) -- The Alzheimer's Drug Discovery Foundation (ADDF) and The Children's Tumor Foundation (CTF) today announced a partnership to provide CTF's scientific...
DiamiR Reports Validation of Two Families of Brain-Enriched microRNAs as Highly Promising Blood-Based Biomarkers of Mild Cognitive Impairment
January 02, 2014 04:00 ET | DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - January 02, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...
Neuronascent, Inc. Announces Issuance of Canadian Patent Covering Its Lead Alzheimer's Disease Candidate
June 25, 2013 12:39 ET | Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - Jun 25, 2013) -  Neuronascent, Inc. announced today the issuance of a Canadian patent covering its compound families that include Neuronascent's Alzheimer's...
MIT Enterprise Forum of Cambridge Presents "Defeating Alzheimer's"
November 30, 2011 08:30 ET | MIT Enterprise Forum
CAMBRIDGE, MA--(Marketwire - Nov 30, 2011) - On December 14, 2011 the MIT Enterprise Forum of Cambridge will present an Innovation Series event: "Defeating Alzheimer's." The disease devastates the...